Caristo Diagnostics

Caristo Diagnostics in the News

1 article

AI Detects Hidden Heart Attack Risk in Half of Patients Traditional Scans Miss
Clinical AI

AI Detects Hidden Heart Attack Risk in Half of Patients Traditional Scans Miss

Oxford-born Caristo Diagnostics wins FDA clearance for first AI platform that measures coronary inflammation from routine CT scans, targeting the 50% of cardiac patients misclassified as low-risk.

Health AI Central Editorial Team·July 30, 2026